Tazumab Injection 440 mg/20 ml contains Trastuzumab, a monoclonal antibody used in the treatment of HER2-positive breast cancer and HER2-positive metastatic gastric cancer. It is a targeted biological therapy designed to specifically act against cancer cells that overexpress the human epidermal growth factor receptor 2 (HER2) protein.

HER2 is a protein that promotes the growth of cancer cells. In certain cancers, particularly some types of breast and gastric cancers, the HER2 gene is amplified, leading to excessive HER2 protein production and aggressive tumor growth. Trastuzumab works by binding selectively to the HER2 receptors on cancer cells. This action blocks the growth signals and helps the immune system identify and destroy these abnormal cells.

Tazumab Injection is an essential component of targeted therapy regimens and has significantly improved treatment outcomes in HER2-positive cancers. It is used either alone or in combination with chemotherapy, depending on the stage and clinical condition of the patient.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Tazumab Injection 440 mg/20 ml is indicated for:

• HER2-positive early breast cancer

• HER2-positive metastatic breast cancer

• HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma

HER2 testing is required before initiating treatment to confirm eligibility, as Trastuzumab is effective only in patients with HER2 overexpression.

Dosage and Administration

Tazumab Injection should be administered under the supervision of a qualified oncologist experienced in cancer chemotherapy. The dosage and treatment schedule depend on the patient’s body weight, cancer type, and whether it is used alone or in combination with other anticancer medicines.

It is given as an intravenous infusion. The first infusion is usually administered over a longer period to monitor for infusion-related reactions, while subsequent doses may be given over a shorter duration if well tolerated.

Patients require regular monitoring during treatment, including assessment of cardiac function, as Trastuzumab may affect heart performance in some individuals.

Benefits and Features

• Targeted therapy specifically for HER2-positive cancers

• Improves survival and reduces recurrence risk in early breast cancer

• Effective in both early-stage and metastatic disease

• Can be combined with chemotherapy for enhanced effectiveness

• Well-established treatment with proven clinical outcomes

Precautions and Warnings

Before starting Tazumab, inform the healthcare provider about any history of heart disease, lung disorders, or previous anthracycline therapy. Cardiac monitoring through echocardiogram or other assessments is recommended before and during treatment.

Infusion-related reactions such as fever, chills, or breathing difficulty may occur, especially during the first dose. Medical supervision is necessary during administration.

Tazumab Injection is not recommended during pregnancy due to potential risk to the fetus. Effective contraception should be used during treatment and for a period after completion, as advised by the physician.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Common side effects may include:

• Fever and chills

• Nausea

• Fatigue

• Diarrhea

• Infusion-related reactions

Serious but less common side effects include heart dysfunction, lung complications, or severe allergic reactions. Immediate medical attention is required if symptoms such as shortness of breath, swelling, or chest discomfort occur.

Storage

Store Tazumab Injection 440 mg/20 ml under refrigerated conditions as directed. Do not freeze. Keep out of reach of children.

Tazumab Injection 440 mg/20 ml (Trastuzumab) is a life-saving targeted therapy for HER2-positive cancers, offering improved survival and better disease control when administered under specialized medical supervision.